Literature DB >> 30743044

Empagliflozin Targeting the Real-World Heart Failure Population.

Bruno M L Rocha1, Rita V Gomes2, Gonçalo J L Cunha3, Gonçalo Mendes4, Rui Morais3, L Campos5, Inês Araújo3, Cândida Fonseca5.   

Abstract

Mesh：

Substances：

Year:  2019        PMID： 30743044     DOI： 10.1016/j.cardfail.2019.02.002

Source DB:  PubMed          Journal:  J Card Fail        ISSN： 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  1 in total

1.  Evidence from routine clinical practice: EMPRISE provides a new perspective on CVOTs.

Authors:  Guntram Schernthaner; Avraham Karasik; Agnė Abraitienė; Alexander S Ametov; Zsolt Gaàl; Janusz Gumprecht; Andrej Janež; Susanne Kaser; Katarina Lalić; Boris N Mankovsky; Evgeny Moshkovich; Marju Past; Martin Prázný; Gabriela Radulian; Lea Smirčić Duvnjak; Ivan Tkáč; Kārlis Trušinskis
Journal:  Cardiovasc Diabetol       Date:  2019-08-31       Impact factor: 9.951
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.